Clinical Trial Details

Trial ID: L0527
Source ID: NCT03222206
Associated Drug: Salsalate
Title: The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease: Investigator Initiated Randomized Placebo-controlled Double-blind, Pilot Study
Acronym: --
Status: Not recruiting
Study Results: No Results Available
Results: --
Conditions: Non Alcoholic Fatty Liver;Osteo Arthritis
Interventions: Drug: Salsalate;Other: Placebo
Outcome Measures: Change of controlled attenuation parameter;Change of hepatokine as Fetuin-A;Change of pulse wave velocity;Change of adipokine as AdiponectinChange of controlled attenuation parameter;Change of hepatokine as Fetuin-A;Change of pulse wave velocity;Change of adipokine as Adiponectin;Numerical value change of fatty liver index;Numerical value change of hepatic fibrosis as Nonalcoholic Fatty Liver Disease(NAFLD) fibrosis score;Change of saccharometabolic factors as Homeostasis Model Assessment(HOMA)-Insulin Resistance(IR), Homeostasis Model Assessment(HOMA)-B, Fasting glucose, Insulin, C-peptide, HbA1c, Glycated albumin;Change of lipid metabolic factors as Cholesterol, Triglyceride, LDL-cholesterol HDL-cholesterol and liver function test as Aspartate Transaminase(AST) and Alanine Transaminase(ALT);Change of inflammatory factors as C Reactive Protein(CRP), Tumor Necrosis Factor(TNF)-a;Change of liver fibrosis factors as hyaluronic acid;Change of symptom of osteoarthritis as visual analog score for pain;Change of function of osteoarthritis as WOMAC (The Western Ontario and McMaster Universities Osteoarthritis Index);Stability comparison like side effect
Sponsor/Collaborators: Korea University Guro Hospital
Gender: All
Age: 19 Yearsnan
Phases: Phase 4
Enrollment: 34
Study Type: Interventional
Study Designs: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Start Date: 08/07/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 12 December 2020
Locations: Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT03222206